Stock Fundamentals

Company Information

Company Name
ProKidney Corp.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: KYG7S53R1049
CIK: 0001850270
Currency: USD
Full Time Employees: 231
Phone: 336 999 7019
Fiscal Year End: December
IPO Date: Jul 12, 2022
Description:

ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Address:

2000 Frontis Plaza Boulevard, Winston-Salem, NC, United States, 27103

Directors & Officers

Name Title Year Born
Dr. Bruce Culleton M.D. CEO & Director 1969
Mr. James Coulston CPA Chief Financial Officer 1977
Mr. Todd C. Girolamo Esq., J.D., M.B.A. Chief Legal Officer & Secretary 1965
Mr. Kenneth Locke Chief Technical Officer NA
Mr. Richard Williams Chief Information Officer NA
Ms. Carla Poulson Chief People Officer NA
Dr. Joseph M. Stavas M.D., M.P.H. SVP of Clinical Affairs NA
Dr. Darin J. Weber Ph.D. Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access 1968
Dr. Emily Butler Ph.D. Senior VP of Biometric NA
Dr. Ulrich Ernst Ph.D. EVP of Science and Technology 1962

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 13, 2025 Brian Jg Pereira N/A Sale 502.14K $2.37 $1.19M
Nov 12, 2025 Brian Jg Pereira N/A Sale 255.03K $2.72 $693.67K
Jul 08, 2025 Darin J. Weber N/A Sale 103.48K $3.02 $312.51K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Suvretta Capital Management, LLC 12.34M Mar 31, 2026 6.02% $0.56 0.00%
Morgan Stanley - Brokerage Accounts 8.96M Mar 31, 2026 4.37% $0.00 1.58%
Millennium Management LLC 2.27M Mar 31, 2026 1.11% $0.00 23.82%
Bleichroeder LP 2.00M Mar 31, 2026 0.98% $0.62 0.00%
Artia Global Partners LP 1.81M Mar 31, 2026 0.88% $0.65 -1.71%
Vanguard Group Inc 1.65M Dec 31, 2025 0.80% $0.00 5.38%
Hennion & Walsh Asset Management Inc 1.61M Mar 31, 2026 0.79% $0.10 7.17%
BlackRock Inc 1.39M Mar 31, 2026 0.68% $0.00 -1.21%
Renaissance Technologies Corp 1.25M Mar 31, 2026 0.61% $0.00 39.64%
Geode Capital Management, LLC 1.23M Mar 31, 2026 0.60% $0.00 2.75%
Vanguard Capital Management, LLC 1.15M Mar 31, 2026 0.56% $0.00 0.00%
Marshall Wace Asset Management Ltd 1.01M Mar 31, 2026 0.49% $0.00 65.19%
Bank of America Corp 753.41K Mar 31, 2026 0.37% $0.00 6.69%
Charles Schwab Investment Management Inc 627.77K Mar 31, 2026 0.31% $0.00 0.75%
State Street Corp 556.85K Mar 31, 2026 0.27% $0.00 15.93%
Vanguard Fiduciary Trust Co 538.37K Mar 31, 2026 0.26% $0.00 0.00%
Woodline Partners LP 500.00K Mar 31, 2026 0.24% $0.00 0.00%
MYDA Advisors LLC 428.78K Mar 31, 2026 0.21% $0.13 -2.55%
The Goldman Sachs Group Inc 421.90K Mar 31, 2026 0.21% $0.00 -38.06%
Two Sigma Investments LLC 346.38K Mar 31, 2026 0.17% $0.00 -25.59%

Shares Statistics

Shares Outstanding: 205.20M
Shares Float: 156.76M
% Insiders: 4,729.80%
% Institutions: 2,438.10%
Short % Float: 11.57%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 NUMC B0-B 3.43M 1.67% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 1.18M 0.58% ▲ 2.84% Apr 30, 2026
3 Morgan Stanley Insight 1.12M 0.55% ▲ 0.00% Mar 31, 2026
4 Morgan Stanley Insight I 1.12M 0.55% ▲ 0.00% Mar 31, 2026
5 BrighthouseI Morgan Stanley Discovery B 1.08M 0.53% ▲ 0.00% Mar 31, 2026
6 GBM104 A 1.00M 0.49% ▲ 0.00% Apr 30, 2026
7 Morgan Stanley Inst Discovery I 820.88K 0.40% ▲ 0.00% Mar 31, 2026
8 Morgan Stanley Discovery 820.88K 0.40% ▲ 0.00% Mar 31, 2026
9 GBM103 A 750.00K 0.37% ▲ 0.00% Apr 30, 2026
10 GBM102 A 700.00K 0.34% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $148.20M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $525.58M
EBITDA: $-161.92M
Book Value: $-7.21
Earnings/Share: $-0.53
Profit Margin: 0.00%
Operating Margin: -19,881.86%
ROA (TTM): -30.15%
ROE (TTM): -49.37%
Revenue (TTM): $889.00K
Revenue/Share (TTM): $0.01
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -1.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 9.13x 0.00x 0.10x -41,251.75x -0.01x
2024-12-31 10.93x 0.00x 0.09x -20,408.44x 0.00x
2023-12-31 14.94x 0.00x 0.07x -12,626.83x -0.01x
2022-12-31 46.42x 0.00x 0.03x -711.66x 0.00x
2021-12-31 2.21x 0.01x 0.33x -27,555.00x -0.01x
2020-12-31 1.02x 0.02x 0.41x -628.47x -0.01x
2019-12-31 5.68x 0.01x 0.19x N/A -0.01x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PROK.US!